BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34529789)

  • 21. High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas.
    Haas RL; Poortmans P; de Jong D; Aleman BM; Dewit LG; Verheij M; Hart AA; van Oers MH; van der Hulst M; Baars JW; Bartelink H
    J Clin Oncol; 2003 Jul; 21(13):2474-80. PubMed ID: 12829665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.
    Wilder RB; Tucker SL; Ha CS; Rodriguez MA; Hess MA; Cabanillas FF; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):17-22. PubMed ID: 11163493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
    Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
    J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiotherapy of follicular lymphoma: updated role and new rules.
    Yahalom J
    Curr Treat Options Oncol; 2014 Jun; 15(2):262-8. PubMed ID: 24700284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation therapy in indolent primary cutaneous B cell lymphoma: a single institute experience.
    De Felice F; Grapulin L; Pieroni A; Salerno F; D'Elia GM; Pulsoni A; Musio D; Tombolini V
    Ann Hematol; 2018 Dec; 97(12):2411-2416. PubMed ID: 30094511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recommendations for the use of radiotherapy in nodal lymphoma.
    Hoskin PJ; Díez P; Williams M; Lucraft H; Bayne M;
    Clin Oncol (R Coll Radiol); 2013 Jan; 25(1):49-58. PubMed ID: 22889569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma.
    Karmali R; Kassar M; Venugopal P; Shammo JM; Fung HC; Bayer R; O'Brien T; Gregory SA
    Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):467-74. PubMed ID: 21700527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Place of low-dose total body irradiation in the treatment of localized follicular non-Hodgkin's lymphoma: results of a pilot study.
    Richaud PM; Soubeyran P; Eghbali H; Chacon B; Marit G; Broustet A; Hoerni B
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):387-90. PubMed ID: 9457825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
    Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.
    Tsang RW; Gospodarowicz MK; Pintilie M; Wells W; Hodgson DC; Sun A; Crump M; Patterson BJ
    J Clin Oncol; 2003 Nov; 21(22):4157-64. PubMed ID: 14615444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results with radiotherapy for Stage I-II follicular lymphomas.
    Wilder RB; Jones D; Tucker SL; Fuller LM; Ha CS; McLaughlin P; Hess MA; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1219-27. PubMed ID: 11728680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose and limited-volume radiotherapy alone for primary dural marginal zone lymphoma: treatment approach and review of published data.
    Puri DR; Tereffe W; Yahalom J
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1425-35. PubMed ID: 18234430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiotherapy Dose and Volume De-escalation in Ocular Adnexal Lymphoma.
    Rehn S; Elsayad K; Oertel M; Baehr A; Eter N; Haverkamp U; Lenz G; Eich HT
    Anticancer Res; 2020 Jul; 40(7):4041-4046. PubMed ID: 32620650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose involved-field radiation in the treatment of non-hodgkin lymphoma: predictors of response and treatment failure.
    Russo AL; Chen YH; Martin NE; Vinjamoori A; Luthy SK; Freedman A; Michaelson EM; Silver B; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2013 May; 86(1):121-7. PubMed ID: 23414765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High local control and low ocular toxicity using ultra-low-dose "boom-boom" radiotherapy for indolent orbital lymphoma.
    Shelukar S; Fernandez C; Bas Z; Komarnicky L; Lally SE; Shields CL; Binder A; Porcu P; Alpdogan O; Martinez-Outschoorn U; Shi W
    Chin Clin Oncol; 2022 Dec; 11(6):44. PubMed ID: 36632978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.
    Senff NJ; Hoefnagel JJ; Neelis KJ; Vermeer MH; Noordijk EM; Willemze R;
    Arch Dermatol; 2007 Dec; 143(12):1520-6. PubMed ID: 18087001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase III randomized controlled trial of radiation dose optimization in non-Hodgkin lymphoma-diffuse large B-cell lymphoma (DOBL study): Study protocol and design.
    Goda JS; Lewis SC; Laskar S; Kannan S; Khanna N; Jain H; Bagal B; Epari S
    Cancer Rep (Hoboken); 2019 Apr; 2(2):e1161. PubMed ID: 32935480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary radiotherapy for localized orbital MALT lymphoma.
    Le QT; Eulau SM; George TI; Hildebrand R; Warnke RA; Donaldson SS; Hoppe RT
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):657-63. PubMed ID: 11849787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiotherapy of indolent orbital lymphomas : Two radiation concepts.
    König L; Stade R; Rieber J; Debus J; Herfarth K
    Strahlenther Onkol; 2016 Jun; 192(6):414-21. PubMed ID: 27160291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose radiotherapy for extranodal marginal zone B lymphoma of the lip: Case report and literature review.
    Bianco L; Solla SD; Parvis G; Gino E; Bollito E; Filippi AR; Massa F; Ruo Redda MG
    Hematol Oncol Stem Cell Ther; 2021 Mar; 14(1):76-81. PubMed ID: 30611712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.